...
首页> 外文期刊>Clinical journal of the American Society of Nephrology: CJASN >Venous Thromboembolism and Membranous Nephropathy: So What's New?
【24h】

Venous Thromboembolism and Membranous Nephropathy: So What's New?

机译:静脉血栓栓塞和膜性肾病:有什么新变化?

获取原文

摘要

The association of venous thromboembolism (VTE) with the nephrotic syndrome, particularly deep vein and renal vein thrombosis (DVT and RVT, respectively) is firmly established (1a€“3). In a retrospective study of 298 nephrotic patients followed for a mean period of 10 years (4), the annual incidence of VTE was 1.02%/yr, and the absolute risk of arterial thrombosis was 1.48%/yr. The risk of both venous and arterial thrombosis was particularly high within the first 6 months of diagnosis (with annual incidences of 9.85% and 5.52%, respectively) (4). In children with the nephrotic syndrome, 9.2% of 326 patients experienced 38 thromboembolic episodes over a median period of 3.7 years (5). This risk is particularly high in patients with idiopathic membranous nephropathy.
机译:静脉血栓栓塞症(VTE)与肾病综合征,特别是深静脉和肾静脉血栓形成(分别为DVT和RVT)之间的联系已得到牢固确立(1a-3)。在一项回顾性研究中,对298名肾病患者进行了平均10年的随访(4),VTE的年发生率为1.02%/年,动脉血栓形成的绝对风险为1.48%/年。在诊断的头六个月内,静脉和动脉血栓形成的风险特别高(年发生率分别为9.85%和5.52%)(4)。在患有肾病综合征的儿童中,326名患者中的9.2%在中位时间3.7年内经历了38次血栓栓塞发作(5)。特发性膜性肾病患者的这一风险特别高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号